Skip to content

13F-HR filed by Foresite Capital Management V, LLC

Foresite Capital Management V, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:24:20 UTC, with 9 holding rows worth $289,147,716.

Accession
0001104659-26-128380
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 9 entries on the cover page, a total value of $289,147,716 stated on the cover page (in dollars after the unit check, H1), rows summing to $289,147,716 with VALUE read as dollars as filed, 13F file number 028-20850. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CG ONCOLOGY INC156944100COMMON STOCK1,079,050$76,493,855dollars as filed
Latigo Biotherapeutics, Inc.517954103Common Stock, par value $0.0001 per share3,562,984$59,501,833dollars as filed
ALUMIS INC022307102COM5,896,995$43,578,793dollars as filed
HIMS & HERS HEALTH INC433000106COM CL A883,751$26,326,942dollars as filed
DISC MEDICINE INC COM254604101Stock374,069$24,486,557dollars as filed
PHARVARIS NVN69605108COMMON STOCK664,142$21,066,584dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK729,602$16,211,756dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK458,742$10,876,773dollars as filed
EIKON THERAPEUTICS INC282564103COMMON STOCK1,318,983$10,604,623dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-128380this filing2026-11-16